GCP Audit of Clinical Evaluations for Japan: Requirements and expectations from the revised Japanese PAL
Instructor:
Phil Smart
Product ID: 700846
- Duration: 60 Min
With revisions to the Pharmaceutical Affairs Law (PAL) and GCP Ordinance 36, there is an increased focus on clinical data and how it is presented to the PMDA/MHLW. A comprehensive audit of relevant clinical investigations is now expected to determine if the clinical trials and clinical trial systems are effectively documented and implemented. This audit should be proceduralized and should be based on both Ordinance 36 as well as ISO 15144 parts 1 and 2.
Areas Covered in the seminar:
- Review of the requirement for clinical data per JPAL, Ordinance 169 and relevant notifications.
- Understanding the requirement to comply with Ordinance 36 Good Clinical Practice for domestic (in Japan) or foreign clinical investigations.
- Focus on the independent audit of clinical investigations to ensure compliance.
- Developing an audit procedure and checklist for GCP clinical investigations.
- Developing an audit checklist for GCP clinical investigations based on ISO 15144 Parts 1 and 2.
- The difference between clinical monitoring and the Japanese GCP audit of clinical investigations.
- Practical aspects of auditing foreign clinical trials for MHLW compliance.
Who will benefit:
This webinar will provide valuable assistance to regulated companies which employ regulatory affairs associates, clinical specialists, internal auditors, audit managers and personnel of JPAL-regulated medical device or IVD companies. The employees who will benefit include:
- Regulatory Managers and related personnel
- Clinical Investigation Managers
- Internal auditors and 2nd-party auditors who deal with assessments of clinical evaluation processes
- Internal process owners who will be audited to the requirements of risk management
- Consultants
Phil Smart, is a founding member of RA/QA International LLC. He serves the medical device community as Consultant, Facilitator and Instructor to 21 CFR Part 820, CMDR/CMDCAS, MDD, MHLW/PMDA/Japanese PAL. He has been a European Notified Body Lead Assessor for over 15 years with auditing experience in a wide range of active and non-active medical device clinical evaluations and clinical monitoring. He was head of TUV PS Japan for several years and continues to provide consultation and independent audit support to ensure effective compliance to Japanese PAL and its ordinances.
More Training By Experts
- Internal Auditing of Risk Management: Emphasis on effectiveness and compliance to QSR, ISO 13485 and ISO 14971
- International GMP's for Medical Devices: Quality System requirements for USA, Europe, Canada and Japan
- Risk Management and Internal Auditing: Effective quality audits with inclusion of ISO 14971:2007
- 4-Region internal audits: Medical Device Quality System audits that cover internal regulatory compliance for FDA, Europe, Canada and Japan
- Japan PAL Audits performed abroad by the PMDA: What to expect and how to prepare
Refund Policy
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
